A citation-based method for searching scientific literature

Atefeh Fakharian, Saghar Barati, Monir Mohamadi, Farzaneh Dastan. J Cardiothorac Vasc Anesth 2021
Times Cited: 4







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
75

Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
Zhe Xu, Lei Shi, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, Shuhong Liu, Peng Zhao, Hongxia Liu, Li Zhu,[...]. Lancet Respir Med 2020
50

Blockage of interleukin-1β with canakinumab in patients with Covid-19.
Lorenza Landi, Claudia Ravaglia, Emanuele Russo, Pierluigi Cataleta, Maurizio Fusari, Andrea Boschi, Diana Giannarelli, Francesca Facondini, Ilaria Valentini, Ilaria Panzini,[...]. Sci Rep 2020
17
50


COVID-19, ACE2, and the cardiovascular consequences.
Andrew M South, Debra I Diz, Mark C Chappell. Am J Physiol Heart Circ Physiol 2020
327
50

Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19.
Raphaël Cauchois, Marie Koubi, David Delarbre, Cécile Manet, Julien Carvelli, Valery Benjamin Blasco, Rodolphe Jean, Louis Fouche, Charleric Bornet, Vanessa Pauly,[...]. Proc Natl Acad Sci U S A 2020
81
50

Effective treatment of severe COVID-19 patients with tocilizumab.
Xiaoling Xu, Mingfeng Han, Tiantian Li, Wei Sun, Dongsheng Wang, Binqing Fu, Yonggang Zhou, Xiaohu Zheng, Yun Yang, Xiuyong Li,[...]. Proc Natl Acad Sci U S A 2020
50

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.
Chi Zhang, Zhao Wu, Jia-Wen Li, Hong Zhao, Gui-Qiang Wang. Int J Antimicrob Agents 2020
898
50

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
Carlos Salama, Jian Han, Linda Yau, William G Reiss, Benjamin Kramer, Jeffrey D Neidhart, Gerard J Criner, Emma Kaplan-Lewis, Rachel Baden, Lavannya Pandit,[...]. N Engl J Med 2021
394
50


Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
John H Stone, Matthew J Frigault, Naomi J Serling-Boyd, Ana D Fernandes, Liam Harvey, Andrea S Foulkes, Nora K Horick, Brian C Healy, Ruta Shah, Ana Maria Bensaci,[...]. N Engl J Med 2020
578
50

Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.
A Conti, C Lasagni, L Bigi, G Pellacani. J Eur Acad Dermatol Venereol 2020
29
50

Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-Jie Guan, Zheng-Yi Ni, Yu Hu, Wen-Hua Liang, Chun-Quan Ou, Jian-Xing He, Lei Liu, Hong Shan, Chun-Liang Lei, David S C Hui,[...]. N Engl J Med 2020
50

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
50

Immunology of COVID-19: Current State of the Science.
Nicolas Vabret, Graham J Britton, Conor Gruber, Samarth Hegde, Joel Kim, Maria Kuksin, Rachel Levantovsky, Louise Malle, Alvaro Moreira, Matthew D Park,[...]. Immunity 2020
722
50

COVID-19 infection in Crohn's disease under treatment with adalimumab.
Antonio Tursi, Gioacchino Angarano, Laura Monno, Annalisa Saracino, Fabio Signorile, Aurelia Ricciardi, Alfredo Papa. Gut 2020
31
50

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, Duncan Richards, Tracy Hussell. Lancet 2020
302
50

Clinical and immunological features of severe and moderate coronavirus disease 2019.
Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, Tao Wang, Xiaoyun Zhang, Huilong Chen, Haijing Yu,[...]. J Clin Invest 2020
50


Mitochondria as a centrally positioned hub in the innate immune response.
Rajat Sandhir, Avishek Halder, Aditya Sunkaria. Biochim Biophys Acta Mol Basis Dis 2017
56
25

Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions.
Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, Thierry Walzer, Bruno François, Pascal Sève. Autoimmun Rev 2020
302
25

Differential Binding of Sarilumab and Tocilizumab to IL-6Rα and Effects of Receptor Occupancy on Clinical Parameters.
Christine Xu, Ashique Rafique, Terra Potocky, Anne Paccaly, Patrick Nolain, Qiang Lu, Melitza Iglesias-Rodriguez, Gregory St John, Michael C Nivens, Vanaja Kanamaluru,[...]. J Clin Pharmacol 2021
7
25

Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses.
L Vincent Collins, Shahin Hajizadeh, Elisabeth Holme, Ing-Marie Jonsson, Andrej Tarkowski. J Leukoc Biol 2004
277
25

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.
Wen Zhang, Yan Zhao, Fengchun Zhang, Qian Wang, Taisheng Li, Zhengyin Liu, Jinglan Wang, Yan Qin, Xuan Zhang, Xiaowei Yan,[...]. Clin Immunol 2020
636
25

Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis.
Joseph Thomas Ortega, Maria Luisa Serrano, Flor Helene Pujol, Hector Rafael Rangel. EXCLI J 2020
131
25

Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy.
David T Selewski, Timothy T Cornell, Neal B Blatt, Yong Y Han, Theresa Mottes, Mallika Kommareddi, Michael G Gaies, Gail M Annich, David B Kershaw, Thomas P Shanley,[...]. Crit Care Med 2012
108
25

Nervous system involvement after infection with COVID-19 and other coronaviruses.
Yeshun Wu, Xiaolin Xu, Zijun Chen, Jiahao Duan, Kenji Hashimoto, Ling Yang, Cunming Liu, Chun Yang. Brain Behav Immun 2020
818
25

Mitochondrial DNA in innate immune responses and inflammatory pathology.
A Phillip West, Gerald S Shadel. Nat Rev Immunol 2017
334
25

COVID-19 Infection in a Patient with End-Stage Kidney Disease.
Dian Fu, Bo Yang, Jing Xu, Zhiguo Mao, Chenchen Zhou, Cheng Xue. Nephron 2020
23
25

The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China.
Yongshi Yang, Fujun Peng, Runsheng Wang, Ming Yange, Kai Guan, Taijiao Jiang, Guogang Xu, Jinlyu Sun, Christopher Chang. J Autoimmun 2020
336
25

Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis under Treatment with Tocilizumab.
Shumpei Yokota, Yasuhiko Itoh, Tomohiro Morio, Naokata Sumitomo, Kaori Daimaru, Seiji Minota. J Rheumatol 2015
57
25

Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Guangdi Li, Erik De Clercq. Nat Rev Drug Discov 2020
772
25

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
Mehmet Soy, Gökhan Keser, Pamir Atagündüz, Fehmi Tabak, Işık Atagündüz, Servet Kayhan. Clin Rheumatol 2020
263
25

Advances in understanding the pathogenesis of HLH.
G Naheed Usmani, Bruce A Woda, Peter E Newburger. Br J Haematol 2013
131
25


Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis.
Alfonso J Rodriguez-Morales, Jaime A Cardona-Ospina, Estefanía Gutiérrez-Ocampo, Rhuvi Villamizar-Peña, Yeimer Holguin-Rivera, Juan Pablo Escalera-Antezana, Lucia Elena Alvarado-Arnez, D Katterine Bonilla-Aldana, Carlos Franco-Paredes, Andrés F Henao-Martinez,[...]. Travel Med Infect Dis 2020
974
25


Melatonin: A Versatile Protector against Oxidative DNA Damage.
Annia Galano, Dun-Xian Tan, Russel J Reiter. Molecules 2018
90
25

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
Yan-Rong Guo, Qing-Dong Cao, Zhong-Si Hong, Yuan-Yang Tan, Shou-Deng Chen, Hong-Jun Jin, Kai-Sen Tan, De-Yun Wang, Yan Yan. Mil Med Res 2020
25

Sarilumab, a fully human monoclonal antibody against IL-6Rα in patients with rheumatoid arthritis and an inadequate response to methotrexate: efficacy and safety results from the randomised SARIL-RA-MOBILITY Part A trial.
Tom W J Huizinga, Roy M Fleischmann, Martine Jasson, Allen R Radin, Janet van Adelsberg, Stefano Fiore, Xiaohong Huang, George D Yancopoulos, Neil Stahl, Mark C Genovese. Ann Rheum Dis 2014
114
25

Innate immune memory: An evolutionary perspective.
Benjamin Gourbal, Silvain Pinaud, Gerold J M Beckers, Jos W M Van Der Meer, Uwe Conrath, Mihai G Netea. Immunol Rev 2018
75
25

Mitochondria: the indispensable players in innate immunity and guardians of the inflammatory response.
Abhishek Mohanty, Rashmi Tiwari-Pandey, Nihar R Pandey. J Cell Commun Signal 2019
45
25

Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.
Jie Ma, Peng Xia, Yangzhong Zhou, Zhengyin Liu, Xiang Zhou, Jinglan Wang, Taisheng Li, Xiaowei Yan, Limeng Chen, Shuyang Zhang,[...]. Clin Immunol 2020
88
25

Cell type-specific involvement of RIG-I in antiviral response.
Hiroki Kato, Shintaro Sato, Mitsutoshi Yoneyama, Masahiro Yamamoto, Satoshi Uematsu, Kosuke Matsui, Tohru Tsujimura, Kiyoshi Takeda, Takashi Fujita, Osamu Takeuchi,[...]. Immunity 2005
980
25

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.
Mizuki Yamamoto, Shutoku Matsuyama, Xiao Li, Makoto Takeda, Yasushi Kawaguchi, Jun-Ichiro Inoue, Zene Matsuda. Antimicrob Agents Chemother 2016
196
25

Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial.
Yuan-Yuan Qin, Yi-Hong Zhou, Yan-Qiu Lu, Feng Sun, Sen Yang, Vijay Harypursat, Yao-Kai Chen. Chin Med J (Engl) 2020
66
25

A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.
Philip Keith, Matthew Day, Linda Perkins, Lou Moyer, Kristi Hewitt, Adam Wells. Crit Care 2020
76
25

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
Shumpei Yokota, Tomoyuki Imagawa, Masaaki Mori, Takako Miyamae, Yukoh Aihara, Shuji Takei, Naomi Iwata, Hiroaki Umebayashi, Takuji Murata, Mari Miyoshi,[...]. Lancet 2008
507
25

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei,[...]. Lancet 2020
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.